Search Results - Mancino, Emaryn

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma

    A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma by Sia, Hanlon, Tan, Peter T., Richter, Joshua, Ho, Phoebe Joy, Cochrane, Tara, Quach, Hang, Dhakal, Binod, Proscurshim, Igor, Jiang, Tony, Mancino, Emaryn, Salhi, Yacine, Stefano, Sammicheli, Gudi, Girish, Garton, Andrew, Feldman, Eric J., Spencer, Andrew

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Final Safety and Efficacy Results from the CPX-351 Early Access Program (EAP) for Older Patients with High-Risk/Secondary Acute Myeloid Leukemia (sAML)

    Final Safety and Efficacy Results from the CPX-351 Early Access Program (EAP) for Older Patients with High-Risk/Secondary Acute Myeloid Leukemia (sAML) by Roboz, Gail J., Larson, Melissa L., Rubenstein, S. Eric, Solomon, Scott R, Schiller, Gary J., An, Qi, Mancino, Emaryn, Chiarella, Michael, Louie, Arthur C., Lin, Tara L

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: